Financial Health Assessment: INTELLING LTD.

1. Financial Health Score: F

Explanation: The patient is in critical condition. Net assets have plummeted to negative £8.18 million, shareholders' funds are deeply insolvent at negative £8.52 million, and cash reserves have haemorrhaged to just £45,299 – a mere 0.17% of total assets. The business is technically insolvent and reliant on the life support of its new parent company, Startek Inc., to continue trading. Without this backing, the prognosis would be terminal.

2. Key Vital Signs

*Note: The apparent improvement in total liabilities from £15.5m to £12.7m is misleading – it primarily reflects the writing off of intercompany balances owed from other Intelling Group Holdings businesses, not genuine debt reduction.

3. Diagnosis

Primary Condition: Severe Financial Insolvency with Acute Cash Depletion

The financial data reveals a business suffering from multiple compounding conditions:

A. Chronic Insolvency (Negative Net Assets) The company's net asset position has deteriorated catastrophically – from a positive £3.17m in 2022, to negative £1.73m in 2023, to negative £8.18m in 2024. This represents a £11.4m swing into the red over just two years. In medical terms, the patient has lost over 350% of their financial "blood volume" – they are bleeding equity at a rate that would be fatal without external intervention.

B. Acute Cash Respiratory Failure Cash reserves have collapsed from £2.78m (2021) to just £45,299 (2024) – a 98.4% depletion. This is the financial equivalent of the patient barely breathing. With approximately £26.8m in turnover, £45k in cash represents roughly 0.06 days of revenue – essentially no liquidity buffer whatsoever. The business cannot self-sustain through any disruption.

C. Margin Compression and Revenue Atrophy Gross margins have contracted from 36.0% to 31.9%, while revenue has declined 3%. In a business with £26.8m turnover, a 4.1 percentage point margin decline represents approximately £1.1m of lost gross profit. The patient's vital organs (core profitability) are shutting down.

D. Exceptional Wounds from Restructuring The acquisition by Startek Inc. in July 2024 has created significant trauma: - £2,531k in exceptional restructuring charges - £3,241k in increased data amortisation costs - Write-off of intercompany balances from other Intelling Group Holdings businesses

These are surgical wounds that, while necessary for the broader group restructuring, have left the UK entity severely weakened.

E. Client Concentration Risk (Pre-existing Condition) The strategic report explicitly acknowledges over-reliance on key BPO clients. The economic downturn has caused these clients to conduct strategic reviews, with anticipated growth failing to materialise. This is akin to a patient dependent on a single organ donor who is themselves falling ill.

F. Intangible Asset Dependency The company continues to value consumer data as an intangible asset (approximately 3.3 million unique records under 3 years old). However, the deliberate reduction in investment in these assets and the significant amortisation charges raise questions about the recoverability and genuine economic value of these intangibles. The balance sheet may be carrying assets that cannot be readily converted to cash – the financial equivalent of phantom tissue.

Secondary Conditions:

• Going Concern Dependency: The company can only continue as a going concern with Startek Inc. support. Without parent company backing, immediate insolvency proceedings would likely be necessary.
• Director Resignation: Philip Morgan's resignation (August 2026 per the data, though this appears to be a future date – likely reflecting a filed future resignation or data error) removes institutional knowledge during a critical transition period.
• Minimal Share Capital: With only £2 in share capital, there is virtually no equity cushion – the company has always operated with minimal permanent capital.

4. Prognosis

Short-term (6-12 months): Guarded – Dependent on Parent Support

The immediate survival of INTELLING LTD. depends entirely on Startek Inc.'s willingness and ability to continue providing financial support. The directors themselves note that underlying performance has "taken a step back in FY25" as key clients conduct strategic reviews. Cash reserves are critically low, and any disruption to parent company funding or client contracts could prove fatal.

Medium-term (1-3 years): Cautiously Optimistic – Conditional on Integration Success

The strategic report expresses confidence in gaining "a larger share of outsourced activities later in 2025 and in 2026" through the Startek relationship. If this materialises, and if the restructuring yields operational efficiencies, the business could stabilise. However, this is speculative and depends on factors outside the company's direct control.

Key Risk Factors:

• Startek Inc. reducing or withdrawing support
• Key BPO clients further reducing spend or terminating contracts
• Failure to achieve anticipated growth in 2025-2026
• Cash flow crisis before restructuring benefits materialise
• Regulatory changes affecting data assets (GDPR compliance costs)

5. Recommendations

Immediate Actions (Critical Care):

1. Cash Flow Stabilisation: Urgently negotiate formalised funding facilities with Startek Inc. to ensure working capital sufficiency. The current £45k cash position is dangerously insufficient. Consider whether parent company loans should be converted to equity to improve the balance sheet.

2. Intercompany Balance Clarity: Obtain and document clear terms for all remaining intercompany arrangements with Startek and other group entities. Ensure these are properly secured and documented to prevent further write-offs.

3. Client Diversification Acceleration: The acknowledged over-reliance on key BPO clients must be addressed urgently. Develop a 12-month pipeline strategy targeting new clients, potentially leveraging Startek's broader client relationships.

Medium-term Actions (Rehabilitation):

4. Margin Recovery Programme: Implement cost reduction initiatives targeting the 4.1 percentage point gross margin decline. Review labour costs, technology infrastructure, and data acquisition costs for efficiency gains.

5. Intangible Asset Review: Conduct a rigorous impairment assessment of the remaining intangible data assets. If amortisation charges of £3.2m+ are recurring, question whether the data investment strategy is generating adequate returns.

6. Working Capital Optimisation: With minimal cash reserves, aggressively manage debtor days, negotiate extended creditor terms where possible, and eliminate non-essential expenditure.

7. Strategic Repositioning: Clarify INTELLING LTD.'s role within the Startek group. If the UK entity is to serve as a European hub, secure the necessary investment. If it is being wound down, manage this in an orderly fashion that maximises creditor recovery.

Monitoring Requirements:

8. Monthly Cash Flow Forecasting: Institute rigorous 13-week rolling cash flow forecasts with variance analysis, reported to both UK management and Startek Inc.

9. Key Client Health Checks: Establish quarterly business reviews with all major clients to identify contract risks early.

10. Going Concern Assessment: The directors must formally assess and disclose going concern status, including the nature and duration of Startek Inc.'s support commitments.